Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 9.717% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccn2c(NC3CCCC3)c(-c3ccsc3)nc2c1
(b) Cc1ccccc1-n1c(Cn2c(=O)sc3ccccc32)nnc1SCC(N)=O
(c) Oc1ccc(-c2cn3c(n2)SCC3)cc1
Answer: b. Cc1ccccc1-n1c(Cn2c(=O)sc3ccccc32)nnc1SCC(N)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1-n1c(Cn2c(=O)sc3ccccc32)nnc1SCC(N)=O
Cc1ccccc1-n1c(Cn2c(=O)sc3ccccc32)nnc1SCC(N)=O
2-[[4-(2-methylphenyl)-5-[(2-oxo-1,3-benzothiazol-3-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]acetamide